Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Non-Current Debt (2020 - 2021)

Historic Non-Current Debt for BioScience Health Innovations (BHIC) over the last 2 years, with Q4 2021 value amounting to $8713.0.

  • BioScience Health Innovations' Non-Current Debt rose 2357.11% to $8713.0 in Q4 2021 from the same period last year, while for Nov 2021 it was $8713.0, marking a year-over-year increase of 2357.11%. This contributed to the annual value of $8713.0 for FY2021, which is 104644.74% up from last year.
  • Per BioScience Health Innovations' latest filing, its Non-Current Debt stood at $8713.0 for Q4 2021, which was up 2357.11% from $8713.0 recorded in Q3 2021.
  • In the past 5 years, BioScience Health Innovations' Non-Current Debt registered a high of $8713.0 during Q3 2021, and its lowest value of $760.0 during Q3 2020.